-
InnoPharmax Inc. (GreTai-E:4172), Taipei, Taiwan SymBio Pharmaceuticals Ltd. (JASDAQ:4582), Tokyo, Japan Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Astellas Pharma Inc. (Tokyo:4503), Tokyo, …
Published on 3/4/2013
-
Alkermes plc (NASDAQ:ALKS), Dublin, Ireland Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Product: Bydureon exenatide; Byetta exenatide; Januvia sitagliptin …
Published on 3/4/2013
-
Merck KGaA (Xetra:MRK), Darmstadt, Germany Product: Cilengitide (Impetreve) (EMD 121974) (formerly NSC 707544) Business: Cancer Molecular target: Integrin alpha(V)beta(3) (CD51/CD61); Integrin alpha(V)beta(5) …
Published on 3/4/2013
-
Durata Therapeutics Inc. (NASDAQ:DRTX), Chicago, Ill. Product: Dalbavancin (RQ-00000002) Business: Infectious Molecular target: D-alanyl-D-alanine Description: Second-generation once-weekly glycopeptide antibiotic …
Published on 3/4/2013
-
Forest Laboratories Inc. (NYSE:FRX), New York, N.Y. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Daxas roflumilast (Daliresp) (…
Published on 3/4/2013
-
KaloBios Pharmaceuticals Inc. (NASDAQ:KBIO), South San Francisco, Calif. Product: KB002 Business: Inflammation Molecular target: Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116) …
Published on 3/4/2013
-
Nektar Therapeutics (NASDAQ:NKTR), San Francisco, Calif. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Product: Naloxegol (formerly NKTR-118) Business: Gastrointestinal Molecular target: Mu opioid receptor (OPRM1) (…
Published on 3/4/2013
-
Genentech Inc., South San Francisco, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Omalizumab(Xolair) (RG3648) Business: Dermatology Molecular …
Published on 3/4/2013
-
Boston Therapeutics Inc. (OTCBB:BTHE), Manchester, N.H. Product: PAZ320 Business: Endocrine/Metabolic Molecular target: NA Description: Chewable polysaccharide that blocks the action of carbohydrate-hydrolyzing enzymes …
Published on 3/4/2013
-
Wilex AG (Xetra:WL6), Munich, Germany Product: Rencarex girentuximab (formerly WX-G250) Business: Cancer Molecular target: Carbonic anhydrase IX (CAIX) Description: Chimeric mAb against carbonic anhydrase IX (CAIX) …
Published on 3/4/2013
-
Anacor Pharmaceuticals Inc. (NASDAQ:ANAC), Palo Alto, Calif. Product: Tavaborole (AN2690) Business: Infectious Molecular target: NA Description: Topical antifungal agent Indication: Treat onychomycosis Endpoint: …
Published on 3/4/2013
-
Circassia Ltd., Oxford, U.K. Product: ToleroMune cat allergy therapy, Cat-PAD Business: Inflammation Molecular target: NA Description: T cell vaccine using ToleroMune T cell epitope desensitization technology Indication…
Published on 3/4/2013
-
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Cambridge, Mass. Product: VX-809 (Lumacaftor) Business: Pulmonary Molecular target: Cystic fibrosis transmembrane conductance regulator (CFTR) Description: Small molecule …
Published on 3/4/2013
-
Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM), Tustin, Calif. Product: Bavituximab (3G4) Business: Cancer Molecular target: Phosphatidylserine Description: Chimeric mAb against phosphatidylserine Indication: Second-line …
Published on 2/25/2013
-
GTx Inc. (NASDAQ:GTXI), Memphis, Tenn. Product: Capesaris (GTx-758) Business: Cancer Molecular target: Estrogen receptor alpha Description: Oral selective estrogen receptor alpha agonist Indication: Treat advanced …
Published on 2/25/2013
-
GTx Inc. (NASDAQ:GTXI), Memphis, Tenn. Product: Capesaris (GTx-758) Business: Cancer Molecular target: Estrogen receptor alpha Description: Oral selective estrogen receptor alpha agonist Indication: Treat metastatic …
Published on 2/25/2013
-
Phytopharm plc (LSE:PYM), Godmanchester, U.K. Product: Cogane (PYM50028) Business: Neurology Molecular target: Glial cell-derived neurotrophic factor (GDNF) Description: Synthetic, orally-active neurotrophic factor …
Published on 2/25/2013
-
MDxHealth S.A. (Euronext:MDXH), Liege, Belgium Product: ConfirmMDx for Prostate Cancer Business: Diagnostic Molecular target: NA Description: Prostate cancer diagnostic based on DNA methylation biomarkers Indication: …
Published on 2/25/2013
-
Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Product: Elaprase idursulfase (HGT2310) Business: Endocrine/Metabolic Molecular target: Not applicable Description: Iduronate-2-sulfatase enzyme Indication: Treat …
Published on 2/25/2013
-
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Product: Eliglustat tartrate (formerly Genz-112638) Business: Endocrine/Metabolic Molecular target: Glucosylceramide synthase (GCS) Description: Ceramide analog that …
Published on 2/25/2013
-
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Product: Eliglustat tartrate (formerly Genz-112638) Business: Endocrine/Metabolic Molecular target: Glucosylceramide synthase (GCS) Description: Ceramide analog that …
Published on 2/25/2013
-
Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Product: HGT1410 Business: Endocrine/Metabolic Molecular target: NA Description: Recombinant human heparan N-sulfatase Indication: Treat mucopolysaccharidosis IIIA (MPS …
Published on 2/25/2013
-
Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY), Solana Beach, Calif. Product: Impracor (TDLP-110) (formerly Ketotransdel) Business: Neurology Molecular target: NA Description: Topical cream formulation of 10% ketoprofen, a…
Published on 2/25/2013
-
Intra-Cellular Therapies Inc., New York, N.Y. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: ITI-214 Business: Neurology Molecular target: Phosphodiesterase-1 (PDE-1) Description: Phosphodiesterase-1…
Published on 2/25/2013
-
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Merck KGaA (Xetra:MRK), Darmstadt, Germany Product: Kuvan (6R-BH4) sapropterin dihydrochloride …
Published on 2/25/2013